Novo says Ozempic to be eligible for US price negotiations in less than a year
Jorgensen is set to testify before a Senate committee on Tuesday in a hearing focused on U.S. prices for its widely popular ...
Novo CEO to blame drug middlemen
The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...
BioWorld32m
Recovery room: Skye, Corbus mend post-Novo CB1 weight-loss data
What the results might mean for the future of other developers in the cannabinoid receptor 1 (CB1) weight-loss arena came into question after Novo Nordisk A/S unveiled phase IIa findings with ...
IPWatchdog36m
Chamber, MSF Weigh in on Senate HELP Committee Hearing with Novo Nordisk CEO
As the Senate Committee on Health, Education, Labor and Pensions (HELP) gears up for a hearing tomorrow titled “Why Is Novo ...
Health Care Down on Obesity Drug Price-War Fears -- Health Care Roundup
Shares of Skye Bioscience gained after the San Diego biopharmaceutical company highlighted the safety of its in-development obesity treatment as compared with rivals. AstraZeneca shares slipped after ...